DAPK1-ERK signal mediates oxygen glucose deprivation reperfusion induced apoptosis in mouse N2a cells

J Neurol Sci. 2018 Apr 15:387:210-219. doi: 10.1016/j.jns.2018.01.003. Epub 2018 Jan 4.

Abstract

Aims: Death-associated protein kinase 1 (DAPK1) is a kinase found to promote neuronal apoptosis induced by ischemia. Extracellular signal-regulated kinase (ERK) was identified as a key molecule in DAPK1 signaling. However, the mechanisms of neuronal ischemia reperfusion injury remain unknown. Here, we investigate the influence of DAPK1-ERK signal on neuronal apoptosis following ischemia reperfusion.

Methods: Mouse N2a cells were used in this study and primary cultured neurons along with mice were adopted as supplements. Oxygen glucose deprivation (OGD) or administration of N-methyl-d-aspartate (NMDA) and glycine was performed on cells while middle cerebral artery occlusion (MCAO) model on mice. DAPK1 knocking down was achieved by lentiviral-delivered shRNA. Protein expressions were evaluated by western blots. Protein-protein binding was confirmed by co-immunoprecipitation and immunofluorescent assay. Apoptosis of cells was measured by flow cytometry and lacate dehydrogenase (LDH) leakage assay.

Results: Ischemia reperfusion resulted in increased DAPK1 and ERK activation as well as aggravated apoptosis in a time-dependent manner. DAPK1 was proved to bind to ERK during reperfusion following OGD, MCAO and excitotoxicity model. Interception of this binding by knocking down DAPK1 led to nuclear translocation of ERK and reduced apoptosis.

Conclusion: Our study revealed the DAPK1-ERK signal as a potential mechanism contributing to neuronal apoptosis in response to ischemia reperfusion. Disruption of this signal pathway could be a promising therapeutic target against stroke.

Keywords: Apoptosis; DAPK1; ERK; Ischemia; Reperfusion injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cell Line, Tumor
  • Cerebral Cortex / cytology
  • Cytarabine / pharmacology
  • Death-Associated Protein Kinases / genetics
  • Death-Associated Protein Kinases / metabolism*
  • Disease Models, Animal
  • Excitatory Amino Acid Agonists / pharmacology
  • Glucose / deficiency*
  • Glycine / pharmacology
  • Hypoxia / physiopathology*
  • Immunosuppressive Agents / pharmacology
  • Infarction, Middle Cerebral Artery / pathology
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • N-Methylaspartate / pharmacology
  • Neuroblastoma / pathology
  • Neurons / drug effects
  • Protein Biosynthesis / drug effects
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism

Substances

  • Excitatory Amino Acid Agonists
  • Immunosuppressive Agents
  • RNA, Small Interfering
  • Cytarabine
  • N-Methylaspartate
  • Dapk1 protein, mouse
  • Death-Associated Protein Kinases
  • Glucose
  • Glycine